Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: Do we enter the era after extended pelvic lymph node dissection?

European Urology

Volumn 64, Issue 6, 2013, Pages 961-963

  Fortuin, Ansje S ^a   Meijer, Hanneke ^a   Thompson, Les C ^b   Alfred Witjes, J ^a   Barentsz, Jelle O ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WESLEY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; FERUMOXITOL; TRACER; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

BLADDER CANCER; CANCER DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; EDITORIAL; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

CONTRAST MEDIA; DEXTRANS; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LYMPH NODES; MAGNETITE NANOPARTICLES; MALE; PROSTATIC NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84887409170     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.08.017     Document Type: Editorial

References (10)

1. A.M. Hövels, R.A. Heesakkers, and E.M. Adang The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis Clin Radiol 63 2008 387 395
2. R.A. Heesakkers, G.J. Jager, and A.M. Hövels Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging Radiology 251 2009 408 414
3. U. Ganswindt, D. Schilling, A.C. Müller, R. Bares, P. Bartenstein, and C. Belka Distribution of prostate sentinel nodes: a SPECT-derived anatomic atlas Int J Radiat Oncol Biol Phys 79 2010 1364 1372
4. L. Wu, Y. Cao, C. Liao, J. Huang, and F. Gao Diagnostic performances of USPIO-enhanced MRI for lymph-node metastases in different body regions: a meta-analysis Eur J Rad 80 2011 582 589
5. F.D. Birkhäuser, U.E. Studer, and J.M. Froehlich Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer Eur Urol 64 2013 953 960
6. A.S. Fortuin, W.M. Deserno, and H.J. Meijer Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases Int J Radiat Oncol Biol Phys 84 2012 712 718
7. R.A. Heesakkers, A.M. Hövels, and G.J. Jager MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study Lancet Oncol 9 2008 850 856
8. A.M. Hövels, R.A. Heesakkers, E.M. Adang, J.O. Barentsz, G.J. Jager, and J.L. Severens Cost-effectiveness of MR lymphography for the detection of lymph node metastases in patients with prostate cancer Radiology 252 2009 729 736
9. A. Fleischmann, S. Schobinger, M. Schumacher, G.N. Thalmann, and U.E. Studer Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases Prostate 69 2009 352 362
10. H.J. Meijer, O.A. Debats, and E.N. van Lin Individualized image-based lymph node irradiation for prostate cancer Nat Rev Urol 10 2013 376 385